Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Monoclonal antibody therapies or biological therapies have been developed to alter the immune response in eosinophilic asthma and nasal polyps. Biologic therapies have been shown to reduce asthma ...

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care ...

Nucala is used with other asthma medications to treat eosinophilic asthma and help prevent asthma attacks. Nucala is prescribed for chronic rhinosinusitis with nasal polyps in adults. Chronic ...

We also found that the levels of PGE2 metabolites in the urine correlated strongly with serum sST2 levels in patients with ...

Blood eosinophil count and fractional exhaled nitric oxide significantly enhance prognostic assessment of asthma attack risk.

Fasenra is approved for treating severe eosinophilic asthma. AZN is also evaluating Fasenra in late-stage studies for treating nasal polyps and COPD among others. Last month, the FDA approved ...

Symptoms of EGPA can vary in patients and may include shortness of breath, sinus problems including nasal ... depletion of eosinophils. 8 The mechanism of action in FASENRA in asthma and EGPA ...

Asthma and Antibiotic Use May Predict Nasal Polyp Recurrence After Endoscopic Sinus Surgery Feb. 4, 2025 — The probability of revision sinus surgery including the removal of nasal polyps is ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...